欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/1130/001
药品名称Levosimendan Kabi 2,5 mg/ml Konzentrat zur Herstellung einer Infusionslösung
活性成分
    • levosimendan 2.5 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Fresenius Kabi Austria GmbH Hafnerstrasse 36 8055 Graz, Austria
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • Hungary (HU)
    • Denmark (DK)
    • Czechia (CZ)
      Levosimendan Kabi
    • Belgium (BE)
      Levosimendan Kabi 2,5 mg/ml concentraat voor oplossing voor infusie
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
      Levosimendan Fresenius Kabi
    • Finland (FI)
    • Poland (PL)
      Levosimendan Kabi
    • Lithuania (LT)
      Levosimendan Kabi 2,5 mg/ml koncentratas infuziniam tirpalui
    • Germany (DE)
      Levosimendan Kabi 2,5 mg/ml Konzentrat zur Herstellung einer Infusionslösung
许可日期2021/12/13
最近更新日期2024/06/13
药物ATC编码
    • C01CX08 levosimendan
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase